buhg1b
17 years ago
Diode Laser Module Offers Increased Brightness And High Reliability
May 12, 2008
Santa Clara, CA - Two new fiber coupled diode laser arrays from Coherent, Inc. offer substantially higher brightness than previously available from the company, without any sacrifice in reliability or lifetime. Specifically, the FAP 200 delivers either >50 W at 976 nm or >30 W at 808 nm from a 200 µm core diameter fiber with a numerical aperture (NA) of 0.22. The FAP 400 provides either >40W at 880 nm or >45W at 808 nm from a 400 µm core diameter fiber having a 0.22 NA. Both these high brightness fiber coupled diode laser arrays utilize Coherent's AAA (aluminum-free active area) technology to achieve industry leading MTTF (mean time to failure) and operating lifetime characteristics.
The FAP 200 and FAP 400 are intended to service a variety of applications in materials processing, such as plastics welding and soldering, as well as solid state laser pumping and therapeutic medical uses. For industrial applications, their higher brightness translates directly into increased process throughput. For laser pumping, high brightness enables increased laser system output.
SOURCE: Coherent Inc., Laser Group
buhg1b
17 years ago
PhAST/Laser Focus World Innovation Award goes to Coherent
May 2, 2008, Washington, DC--The Photonic Applications, Systems and Technologies (PhAST) Conference and Laser Focus World magazine are pleased to announce that Coherent has been selected as the recipient of this year's PhAST/Laser Focus World Innovation Award for its OPSL-577-3, the twin embodiment of technical and application innovation in exploiting the wavelength and power scalability of optically pumped semiconductor laser (OPSL) technology.
"Coherent is leading the pack in the development of precisely scalable lasers for customizable use in a variety of applications," said PhAST Co-Chair David Huff. "This new laser not only advances how the photonics industry can apply laser technology, but also offers hope for the thousands of sufferers of macular degeneration." Coherent will be accepting this award at the CLEO Plenary session on Monday, May 5 at 6 p.m. in the San Jose Civic Auditorium at the San Jose McEnery Convention Center in San Jose, CA.
The OPSL-577-3 is the first laser to fully exploit the wavelength and power scalability of OPSL technology to deliver several watts at an application-optimized wavelength rather than a legacy wavelength. From an applications viewpoint, the 577 nm output brings the promise of a significant improvement in photocoagulation treatment for the many sufferers of wet-form macular degeneration, a leading cause of age-related blindness that affects up to 250,000 people in the United States alone.
The laser is expected to significantly enhance the efficacy of photocoagulation as a treatment modality for wet-form macular degeneration. This disease is episodic in nature, characterized by periodic ruptures of small blood vessels in the retina. The goal of laser photocoagulation is to seal the leaking vessel without damaging peripheral tissue. Since leaking blood is the main differentiating material between the target area and surrounding tissue, this goal can best be achieved by using a laser wavelength that is selectively and effectively absorbed by blood. Moreover, this should be a visible laser wavelength, allowing it to be delivered through the front of the eye without any damage to the lens or aqueous humor.
"The innovation awards are a great opportunity to recognize excellence in the lasers and electro-optics industry," said Steve Andersen, editor-in-chief, Laser Focus World. "We had a number of strong submissions for this year's awards and are impressed with the advances CLEO exhibiting companies are making in the field."
In addition to the award given to Coherent, five honorable mention products were chosen from all entries. The honorable mentions are as follows:
Amplitude Systemes
TANGERINE: 20W High Energy Diode-Pumped Ultrafast Fiber Amplifier
For the introduction of a unique ultrafast fiber amplifier, offering both a high energy level and a high average power.
ColdQuanta
The RuBECi Ultracold Matter Cell
For the development of the industry's first commercial instrument designed to enable the production of Bose-Einstein Condensates (BECs) and related forms of ultracold matter.
Edmund Optics
Low-cost, Color Corrected Aspheres
For presenting the industry's first color-corrected aspherical components.
Holochip
Adaptive Polymer Lens: APL-1050
For introducing an adaptive polymer, singlet fluidic lens with a variable focal length.
Picometrix
T-Ray 4000 Time Domain Terahertz Product Platform
For creating a transportable terahertz system that is precise enough for manufacturing, process control or data collection.
The honorable mentions will be recognized by the PhAST chairs during the CLEO Plenary Session.
The PhAST/Laser Focus World Innovation Award Program honors the most timely, ground-breaking products in the field of laser science. Entries are evaluated on criteria critical to product success: impact, functionality, life expectancy, effect on the optics industry, innovation and patents or trademarks.
For more information on the PhAST/Laser Focus World Innovation Award, visit www.phastconference.org/innovation/.
Thu May 01 21:58:00 CDT 2008
http://www.laserfocusworld.com/display_article/327566/12/none/none/INDUS/PhAST/Laser-Focus-World-Innovation-Award-goes-to-Coherent
buhg1b
17 years ago
Coherent to outsource Auburn optics manufacturing operations
April 18, 2008, Santa Clara, CA--Coherent entered into a definitive agreement to sell certain assets of Coherent's Auburn Optics manufacturing operation to Research Electro-Optics (Boulder, CO), a privately held optics manufacturing and technology company. Consistent with the asset transaction, Coherent and REO have entered into a strategic supply agreement whereby REO will provide optical manufacturing capabilities for Coherent, including fabrication and coating of optical components.
The transition of the optics manufacturing assets from Auburn to Boulder will begin immediately and is expected to be completed no later than the end of the second quarter of fiscal 2009. Coherent will further discuss the transaction during its previously announced second fiscal quarter financial results conference call on April 24, 2008 at 1:30 p.m. PST.
According to an article in The Union newspaper (Grass Valley, CA), the outsourcing move will affect the jobs of about 100 people, including residents who live in southern Nevada County. "It's part of the company's strategy to effectively manage production in cost-effective ways," said Leen Simonet, executive VP and CFO of Coherent. Simonet denied any hardship to local workers, as they would be offered jobs at Research Electro-Optics or provided with help to find work locally. Simonet would not comment on the future of Coherent's manufacturing presence in Auburn. It was unclear whether any manufacturing jobs remain.
For more information, visit www.coherent.com.
Fri Apr 18 09:42:00 CDT 2008
http://www.laserfocusworld.com/display_article/326220/12/none/none/INDUS/Coherent-to-outsource-Auburn-optics-manufacturing-operations
buhg1b
17 years ago
Coherent Earnings Conference Call (Q2 2008)
Scheduled to start Thu, Apr 24, 2008, 4:30 pm Eastern
http://biz.yahoo.com/cc/7/91917.html
After the event has finished, the audio will be available
from this page until Sat, Apr 25, 2009
buhg1b
17 years ago
Dutch Auction
Tuesday March 25, 6:00 am ET
Coherent acquires 7,972,313 shares at $28.50 per share
SANTA CLARA, Calif., March 25 /PRNewswire-FirstCall/ -- Coherent, Inc. (Nasdaq: COHR - News) today announced the final results of its modified "Dutch Auction" tender offer, which expired at 5:00 p.m., New York City time, on Monday, March 17, 2008.
Based on the final count by the depositary for the tender offer, Coherent accepted for payment an aggregate of 7,972,313 shares of its common stock at a purchase price of $28.50 per share. These shares represent approximately 25% of the shares issued and outstanding.
Based on the final count by the depositary for the tender offer, an aggregate of 7,972,313 shares were properly tendered and not withdrawn at or below a price of $28.50. The 7,972,313 shares purchased are comprised of the 7,628,000 shares Coherent offered to purchase and 344,313 shares purchased pursuant to Coherent's right to purchase up to an additional 2% of the outstanding shares, without extending the tender offer in accordance with applicable securities laws.
The depositary will promptly pay for the shares accepted for purchase. All shares tendered and delivered at prices between $28.75 and $29.50 per share will be returned promptly to shareholders by the depositary.
The self-tender offer was made pursuant to an Offer to Purchase and Letter of Transmittal, each dated February 15, 2008, in which the Company offered to purchase up to 7,628,000 shares at a price not less than $26.00 per share and not greater than $29.50 per share, filed with the Securities and Exchange Commission on February 15, 2008, as amended on March 7, 2008 and March 18, 2008.
Merrill Lynch & Co. is the Company's dealer manager for the tender offer. The information agent is Georgeson Inc., and the depositary is American Stock Transfer & Trust Company. Any questions with regard to the tender offer may be directed to the information agent, at 877-868-4962.
Founded in 1966, Coherent, Inc. is a world leader in providing photonics based solutions to the commercial and scientific research markets.
Please direct any questions to Leen Simonet, Executive Vice President and Chief Financial Officer at 408-764-4161.
http://biz.yahoo.com/prnews/080325/aqtu021.html?.v=48
buhg1b
17 years ago
Coherent F1Q08 (Qtr End 12/29/07) Earnings Call Transcript
"...We reported first quarter revenues of $144.3 million and net income of $4.7 million or $0.15 per diluted share. Excluding the charges related to the restatement of our financial statements and litigation resulting from the stock-option investigation and excluding the quarterly stock compensation charges, the pro forma net income for the first quarter of fiscal 2008 was $9.5 million or $0.30 per diluted shares, compared to a pro forma net income of $0.37 per diluted share for the first quarter of fiscal 2007.
The primary reasons for the decline in pro forma earnings related to the increase of period expenses resulting from a weakened dollar. During this period, the euro strengthened approximately 13%.
Bookings for the quarter were strong at $154.9 million, an increase by 13.7% over the corresponding prior year period. Our book-to-bill was 1.07 and the backlog at the end of Q1 '08 was $198.4 million. Net sales for the first quarter were $144.3 million and are within guidance, but as low-end primarily as the result of delivery push ups from a few customers not due to lot business.
Market perspective, when comparing to the similar quarter last year, we saw strong performance in material processing, bioinstrumentation and medical applications, resulting in a 26.5% growth for material processing and 14.5% for OEM components and instrumentations, when adjusted for the sales of optical imaging business. Microelectronics sales declined 12.7% as a result of the slow demand that we saw in the flat panel display market during the second half of fiscal 2007, coupled with normal timing of demand in other micro materials processing markets. The scientific market decline of 8.5% is primarily the results of our previously announced exit from the custom laser business.
Please note that effective Q1 '08, we are consolidating the graphic arts and display business into the OEM components and instrumentations markets. Prior period's market information has been combined to confirm to the current presentation. The Company sales by market applications for the first quarter of fiscal 2008 are as follows; Scientific 30.1; microelectronics, 48.7; material processing, 24.5; and OEM components and instrumentations, 41 for a total of 144.3 million.
First quarter gross profit was $60.5 million or 41.9% of sales. On a pro forma basis, excluding stock compensation costs, gross profit of 42.2% is similar to the first quarter of 2007. The projected accretion of having no imaging uptick revenue and lower scientific custom business was offset by the negative impact of the weak dollar and it continued unfavorable microelectronics market and product mix.
When comparing to the previous quarter pro forma gross profit increased slightly from 41.9% to 42.2%, and this sequential increase was primarily related to improve yields across several of our business units.
Total operating expenses for the quarter, excluding intangible amortization of $2.2 million, excluding the restatement of financial statements of litigation costs related to our stock-option investigation up $4.7 million, and excluding stock compensation charges of $2.3 million was $50.1 million or 34.7% of sales..."
http://seekingalpha.com/article/64339-coherent-f1q08-qtr-end-12-29-07-earnings-call-transcript?source=yahoo
Level up your trading with our powerful tools and real-time insights all in one place.
PonkenPlonken
1 month ago
12yearplan
2 years ago
mkendra
7 years ago
Penny Roger$
13 years ago
Hot Features
Premium
